Connecta Therapeutics
Company Details
Status: Private
Employees: 1-10
Location:
Barcelona, Spain
Type:
sample
Technology:
sample
sample
About: CONNECTA Therapeutics S.L. is a biotechnology company that develops new treatments for CNS unmet medical needs.
The company is initially focus on the clinical development of a new “first-in-class” molecule for the treatment of fragile X syndrome (FXS). FXS is the most common cause of hereditary intellectual disability and there are no therapeutic interventions currently available.
The molecule was discovered after evaluating more than 30 molecular and cellular targets. The molecule has been proven, in in vitro tests and in vivo in animal models, to be an excellent neuroplasticity modulator with a great extension profile for other neurodevelopmental disorders (Rett syndrome, Down syndrome and autism spectrum disorders, among others).
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Connecta Therapeutics | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.